A newly developed immunoliposome - an egg phosphatidylcholine liposome coated with pullulan bearing both a cholesterol moiety and an IgMs fragment

Junzo Sunamoto, Toshinori Sato, Masaki Hirota, Kiyoyasu Fukushima, Kazuhito Hiratani, Kohei Hara

Research output: Contribution to journalArticle

85 Citations (Scopus)

Abstract

An improved methodology for providing a more stable and targetable drug carrier has been developed. This method involves the synthesis of a newly designed immunoliposome by coating the outermost surface of large oligolamellar vesicles of egg phosphatidylcholine with the polysaccharide pullulan, modified to carry both cholesterol, as the hydrophobic anchor, and the monoclonal antibody fragment (anti-sialosyl LewisX, IgMs) as the sensory device. Compared with the binding of pullulan-coated liposomes, that of this immunoliposome to specific cells in vitro was significantly increased by factors of 447 to PC-9 and 295 to KATO-III, but only by a factor of 148 to the less specific cell, 3LL. This strong and specific binding of the immunoliposome to the cell surface of PC-9 was also confirmed by a fluorescence-microscopic investigation using the immunoliposome, which bore the hydrophobic fluorescent probe, terbium trisacetylacetonate, in the liposomal membrane.

Original languageEnglish
Pages (from-to)323-330
Number of pages8
JournalBBA - Biomembranes
Volume898
Issue number3
DOIs
Publication statusPublished - 1987 Apr 23
Externally publishedYes

Fingerprint

Bearings (structural)
Phosphatidylcholines
Liposomes
Ovum
Cholesterol
Terbium
Immunoglobulin Fragments
Drug Carriers
Anchors
Fluorescent Dyes
Polysaccharides
Fluorescence
Monoclonal Antibodies
Membranes
Coatings
Equipment and Supplies
pullulan

Keywords

  • (Human cancer cell line)
  • Cell surface binding
  • Drug carrier
  • Fluorescence
  • Immunoliposome
  • Monoclonal antibody

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Cell Biology
  • Medicine(all)

Cite this

A newly developed immunoliposome - an egg phosphatidylcholine liposome coated with pullulan bearing both a cholesterol moiety and an IgMs fragment. / Sunamoto, Junzo; Sato, Toshinori; Hirota, Masaki; Fukushima, Kiyoyasu; Hiratani, Kazuhito; Hara, Kohei.

In: BBA - Biomembranes, Vol. 898, No. 3, 23.04.1987, p. 323-330.

Research output: Contribution to journalArticle

Sunamoto, Junzo ; Sato, Toshinori ; Hirota, Masaki ; Fukushima, Kiyoyasu ; Hiratani, Kazuhito ; Hara, Kohei. / A newly developed immunoliposome - an egg phosphatidylcholine liposome coated with pullulan bearing both a cholesterol moiety and an IgMs fragment. In: BBA - Biomembranes. 1987 ; Vol. 898, No. 3. pp. 323-330.
@article{e3c249c79bef402f92d4367660ef1a91,
title = "A newly developed immunoliposome - an egg phosphatidylcholine liposome coated with pullulan bearing both a cholesterol moiety and an IgMs fragment",
abstract = "An improved methodology for providing a more stable and targetable drug carrier has been developed. This method involves the synthesis of a newly designed immunoliposome by coating the outermost surface of large oligolamellar vesicles of egg phosphatidylcholine with the polysaccharide pullulan, modified to carry both cholesterol, as the hydrophobic anchor, and the monoclonal antibody fragment (anti-sialosyl LewisX, IgMs) as the sensory device. Compared with the binding of pullulan-coated liposomes, that of this immunoliposome to specific cells in vitro was significantly increased by factors of 447 to PC-9 and 295 to KATO-III, but only by a factor of 148 to the less specific cell, 3LL. This strong and specific binding of the immunoliposome to the cell surface of PC-9 was also confirmed by a fluorescence-microscopic investigation using the immunoliposome, which bore the hydrophobic fluorescent probe, terbium trisacetylacetonate, in the liposomal membrane.",
keywords = "(Human cancer cell line), Cell surface binding, Drug carrier, Fluorescence, Immunoliposome, Monoclonal antibody",
author = "Junzo Sunamoto and Toshinori Sato and Masaki Hirota and Kiyoyasu Fukushima and Kazuhito Hiratani and Kohei Hara",
year = "1987",
month = "4",
day = "23",
doi = "10.1016/0005-2736(87)90073-3",
language = "English",
volume = "898",
pages = "323--330",
journal = "Biochimica et Biophysica Acta - Biomembranes",
issn = "0005-2736",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - A newly developed immunoliposome - an egg phosphatidylcholine liposome coated with pullulan bearing both a cholesterol moiety and an IgMs fragment

AU - Sunamoto, Junzo

AU - Sato, Toshinori

AU - Hirota, Masaki

AU - Fukushima, Kiyoyasu

AU - Hiratani, Kazuhito

AU - Hara, Kohei

PY - 1987/4/23

Y1 - 1987/4/23

N2 - An improved methodology for providing a more stable and targetable drug carrier has been developed. This method involves the synthesis of a newly designed immunoliposome by coating the outermost surface of large oligolamellar vesicles of egg phosphatidylcholine with the polysaccharide pullulan, modified to carry both cholesterol, as the hydrophobic anchor, and the monoclonal antibody fragment (anti-sialosyl LewisX, IgMs) as the sensory device. Compared with the binding of pullulan-coated liposomes, that of this immunoliposome to specific cells in vitro was significantly increased by factors of 447 to PC-9 and 295 to KATO-III, but only by a factor of 148 to the less specific cell, 3LL. This strong and specific binding of the immunoliposome to the cell surface of PC-9 was also confirmed by a fluorescence-microscopic investigation using the immunoliposome, which bore the hydrophobic fluorescent probe, terbium trisacetylacetonate, in the liposomal membrane.

AB - An improved methodology for providing a more stable and targetable drug carrier has been developed. This method involves the synthesis of a newly designed immunoliposome by coating the outermost surface of large oligolamellar vesicles of egg phosphatidylcholine with the polysaccharide pullulan, modified to carry both cholesterol, as the hydrophobic anchor, and the monoclonal antibody fragment (anti-sialosyl LewisX, IgMs) as the sensory device. Compared with the binding of pullulan-coated liposomes, that of this immunoliposome to specific cells in vitro was significantly increased by factors of 447 to PC-9 and 295 to KATO-III, but only by a factor of 148 to the less specific cell, 3LL. This strong and specific binding of the immunoliposome to the cell surface of PC-9 was also confirmed by a fluorescence-microscopic investigation using the immunoliposome, which bore the hydrophobic fluorescent probe, terbium trisacetylacetonate, in the liposomal membrane.

KW - (Human cancer cell line)

KW - Cell surface binding

KW - Drug carrier

KW - Fluorescence

KW - Immunoliposome

KW - Monoclonal antibody

UR - http://www.scopus.com/inward/record.url?scp=0023662836&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023662836&partnerID=8YFLogxK

U2 - 10.1016/0005-2736(87)90073-3

DO - 10.1016/0005-2736(87)90073-3

M3 - Article

C2 - 3567185

AN - SCOPUS:0023662836

VL - 898

SP - 323

EP - 330

JO - Biochimica et Biophysica Acta - Biomembranes

JF - Biochimica et Biophysica Acta - Biomembranes

SN - 0005-2736

IS - 3

ER -